These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6830933)

  • 21. [Comparison of the therapeutic effects of lofepramine and maprotiline in depression].
    Finke G; Wegener G
    MMW Munch Med Wochenschr; 1982 Mar; 124(12):301-3. PubMed ID: 6804813
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of essential tremor by propranolol: correlation of effect with intensity of beta-adrenergic blockade.
    McAllister RG; Markesbery WR; Ware RW; Howell SM
    Trans Am Neurol Assoc; 1976; 101():267-9. PubMed ID: 195382
    [No Abstract]   [Full Text] [Related]  

  • 23. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A; Orefice G; Carrieri P
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract]   [Full Text] [Related]  

  • 24. [Further clinical experiences with maprotiline in endogeneous depressions].
    Náhunek K; Svestka J; Rysánek R; Cesková E
    Act Nerv Super (Praha); 1982 May; 24(2):81-7. PubMed ID: 7048835
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ambulatory treatment of larvate depressions with maprotiline ].
    Vencovský E
    Cesk Psychiatr; 1982 Jun; 78(3):185-9. PubMed ID: 7116496
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of maprotiline on target symptoms of depressive states].
    Faltus F
    Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of therapy-resistant depression with Ludiomil].
    Pethö B; Karczag I
    Orv Hetil; 1983 Oct; 124(44):2683-5. PubMed ID: 6359009
    [No Abstract]   [Full Text] [Related]  

  • 29. Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels.
    Sørensen PS; Paulson OB; Steiness E; Jansen EC
    Ann Neurol; 1981 Jan; 9(1):53-7. PubMed ID: 7212666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Depressive states, occurrence and treatment in family practice. Randomized study of the efficacy of maprotiline (Ludiomil) and flupenthixol (Fluanxol)].
    Sederberg-Olsen P; Lauritsen B; Husfeldt P; Rønne H; Ekstrøm K; Bjørndal F; Holst B; Jakobsen K
    Ugeskr Laeger; 1981 May; 143(22):1383-7. PubMed ID: 7027568
    [No Abstract]   [Full Text] [Related]  

  • 31. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of rare side effects of certain antidepressive drugs].
    Haenel T; Stöckli HR; Truog P
    Nervenarzt; 1995 Jan; 66(1):70-2. PubMed ID: 7885518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognizing and treating depressed patients with maprotiline.
    Lerfald SC
    Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
    [No Abstract]   [Full Text] [Related]  

  • 34. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

  • 35. [A profile of the clinical effectiveness of second generation antidepressive agents].
    Kabes J; Dostal T; Balon R; Papezová H
    Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of the efficacy of EEG after maprotiline administration].
    Libiger J; Hanus H; Kindernayová H; Valach M; Zapletálek M
    Act Nerv Super (Praha); 1982 May; 24(2):106-11. PubMed ID: 7102222
    [No Abstract]   [Full Text] [Related]  

  • 37. [Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
    Rektor L; Misaurec J; Horká E; Cerná V
    Act Nerv Super (Praha); 1982 May; 24(2):101-5. PubMed ID: 7102221
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The antidepressive maprotiline: symposium at Hradec Kralove 26 November 1980].
    Act Nerv Super (Praha); 1982 May; 24(2):39-118. PubMed ID: 7102224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.